title: Methodological approach to brain-derived neurotrophic factor plasma levels in major depressed patients receiving duloxetine.
authors: Department of Biochemistry, Agri Military Hospital, Agri, Turkey, mehmetagilli@yahoo.com.
authors: Mehmet
authors: M
authors: Agilli
authors: Fevzi Nuri
authors: FN
authors: Aydin
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood*; D003865:Major Depressive Disorder / Q000097:blood* / Q000188:drug therapy*; D000068736:Duloxetine Hydrochloride / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D000068736:Duloxetine Hydrochloride
references: J Neurosci. 1995 Mar;15(3 Pt 1):1768-77
references: 7891134
references: Psychoneuroendocrinology. 2011 May;36(4):523-30
references: 20933336
references: Neurol Sci. 2015 May;36(5):729-34
references: 25501804
references: Nutr Neurosci. 2015 May;18(4):162-8
references: 24621065
references: Growth Factors. 2004 Sep;22(3):123-31
references: 15518235
references: Hum Reprod. 2007 Apr;22(4):995-1002
references: 17251358
references: Public Health Nutr. 2013 Oct;16(10):1768-81
references: 23021313